Remedy Q1 next Wednesday: In the investment phase

By Atte Riikola
We have made changes to our quarterly estimates ahead of Remedy's Q1 report on April 26 at 9.00 am. On an annual basis, our estimates are largely unchanged, and this year Remedy is still in a clear investment phase as the company builds its strategy for the next phase of growth with 5 major game projects under development. However, the end of the year will see the start of the company's investor story with the release of Alan Wake 2, which is also a key near-term driver for the stock.
Login required
This content is only available for logged in users